A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

This real-world study is tracking how well obinutuzumab-based therapy works for people newly diagnosed with follicular lymphoma (a slow-growing type of blood cancer) in routine clinical practice outside of a controlled trial setting. **You may be eligible if...** - You have been diagnosed with CD20-positive follicular lymphoma, Grade 1, 2, or 3A - You have never received treatment for this lymphoma - You are 18 or older and have measurable disease on a CT or PET scan - Your doctor has decided you need treatment and that obinutuzumab-based therapy is appropriate **You may NOT be eligible if...** - Your follicular lymphoma has transformed to a more aggressive type or is Grade 3B - You are HIV-positive, or have active hepatitis B or C infection - Your lymphoma has spread to the brain or spinal fluid - There are contraindications to the planned treatment Talk to your doctor to see if this trial is right for you.